Repeated CXL safe and effective for progressive keratoconus

Article

Because the disease is vision-threatening, the investigators retrospectively reviewed the demographic, clinical, and surgical data from the cases of patients who required additional CXL.

Image credit: © mik_cz - stock.adobe.com

Epithelial-off CXL can stabilize keratoconus, but the disease can continue to progress. (Image credit: Adobe Stock/mik_cz)

Israeli investigators reported that after the initial collagen crosslinking (CXL) for progressive keratoconus fails, the procedure can be repeated because it is safe and efficacious,1 according to lead author Ofri Vorobichik Berar, MD, and colleagues from the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel.

Epithelial-off CXL can stabilize keratoconus, but the disease can continue to progress. Because the disease is vision-threatening, the investigators retrospectively reviewed the demographic, clinical, and surgical data from the cases of patients who required additional CXL.

The researchers identified 9 patients (10 eyes) with progressive keratoconus after an initial CXL procedure. The mean patient age when keratoconus was diagnosed was 20.2 years. The patients underwent a repeat CXL procedure and were followed for a mean of 2.1 years.

The data showed the mean best-corrected visual acuity remained stable during follow-up.

They reported that the mean baseline Kmax was 60.4 diopters (D). Before the second CXL procedure, the, Kmax had progressed significantly (P = 0.018) to 62.2 D; at the last follow-up, examination, the Kmax decreased significantly (P = 0.037) to 60.3 D. The mean baseline minimal pachymetry was 464.0 microns. Before the repeated CXL, the minimal pachymetry was significantly lower (P = 0.018), and after the repeated CXL procedure, the minimal pachymetry was stable (P = 0.2). No intraoperative or postoperative complications were noted.

The study concluded, “Repeated CXL is a safe and effective treatment option when failure of the initial CXL is diagnosed, even in young patients. This procedure may prevent visual deterioration and a potential need for keratoplasty.”

Reference
1. Vorobichik Berar O, Rotenberg M, Berger Y, et al. Safety and efficacy of repeated corneal collagen crosslinking in progressive keratoconus. Cornea. 2023;42:423-8; DOI: 10.1097/ICO.0000000000003165
Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
© 2025 MJH Life Sciences

All rights reserved.